Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 500184 | NSE Symbol : HSCL | ISIN : INE019C01026 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
04-Apr-2025	03-Apr-2025	Acquisitions	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we would like to inform you that the Board of Directors ('Board') of Himadri Speciality Chemical Ltd ('Company') at its' meeting held today i.e. on 03 April 2025, has inter-alia considered and approved the Acquisition of 60% equity shares of Trancemarine and Confreight Logistics Private Limited and related transactions The Board of Directors at its meeting held on 03.04.2025 has inter-alia considered and approved acquisition of 60% equity shares of Trancemarine and Confreight Logistics Private Limited and related transactions
29-Mar-2025	29-Mar-2025	Conversion	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we would like to inform you that the Board of Directors ('Board') of Himadri Speciality Chemical Ltd ('Company') at its' meeting held today i.e. on 29 March 2025, has inter-alia considered and approved the following: 1. Conversion of 30,00,000 no. of 0.01% Secured Optionally Convertible Debentures (OCDs) held by the Company into equity shares of Birla Tyres Limited ('BTL or Target Company 1') and subsequent acquisition of 9,999 existing equity shares of BTL held by Dalmia Bharat Refractories Limited; 2. Conversion of 1,44,118 no. of 0.01% Unsecured Optionally Convertible Debentures (OCDs) held by the Company, into equity shares of Himadri Birla Tyre Manufacturer Private Limited ('HBTMPL or Target Company 2'); Outcome of Board Meeting held on 29.03.2025 1. Conversion of 3000000 no of 0.01% secured optionally convertible Debenture (OCDs) held by the Company into equity shares of Birla Tyres Limited (BTL) and subsequent acquisition of 9999 existing equity shares of BTL held by Dalmia Bharat Refractories Limited 2. Conversion of 144118 no of 0.01% Unsecured Optionally convertible Debenture (OCDs) held by the Company, into equity shares of Himadri Birla Tyre Manufacturer Private Limited
27-Jan-2025	27-Jan-2025	Change in Directors	Pursuant to Regulation 30 of the SEBI Listing Regulations, we would like to inform you that the Board of Directors ('Board') of Himadri Speciality Chemical Ltd ('Company') at its' meeting held today i.e. on 27 January 2025, inter-alia has considered and approved the Re-appointment of Whole-time Director. The Board based on the recommendation of the Nomination and Remuneration Committee, has re-appointed Mr. Shyam Sundar Choudhary (DIN: 00173732) as a Whole-time Director for a further term of 3 years with effect from 01 April 2025 upto 31 March 2028 (both days inclusive), subject to approval of the Members of the Company. Disclosures required under Regulation 30 read with Schedule III of the SEBI Listing Regulations read along with SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as 'Annexure-I'. The Meeting of the Board of Directors commenced at 6:15 p.m. (IST) and concluded at 6:50 p.m. (IST) Pursuant to Regulation 30 of the SEBI Listing Regulations we would like to inform you that the Board of Directors at its meeting held on 27 January 2025 inter-alia has considered and approved the re-appointment of Mr. Shyam Sundar Choudhary as a Whole-time Director
06-Jan-2025	13-Jan-2025	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/01/2025 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Monday 13 January 2025 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for quarter and nine months ended 31 December 2024. Un-Audited Financial Results for the quarter and nine-months ended 31.12.2024 (As Per BSE Announcement Dated on: 13/01/2025)
09-Oct-2024	16-Oct-2024	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Wednesday 16 October 2024 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for quarter and six months ended 30 September 2024. Financial Results for the quarter and six- months ended 30 September 2024 We would like to inform you that the Board at its meeting held today, i.e., on 16 October 2024, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six-months ended 30 September 2024. Read less.. (As Per BSE Announcement Dated on 16.10.2024)
09-Jul-2024	16-Jul-2024	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/07/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Tuesday the 16 July 2024 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter ended 30 June 2024. We would like to inform you that the Board at its meeting held on 16.07.2024 inter-alia has considered and approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2024. (As Per BSE Announcement dated on 16.07.2024)
18-Apr-2024	25-Apr-2024	Accounts	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Thursday 25 April 2024 inter-alia to consider the following: 1. To approve and take on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2024; 2. To recommend payment of Dividend if any Further pursuant to the Code of Conduct to Regulate Monitor and Report Trading by Designated Persons and their immediate relatives under SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in securities of the Company which was closed from 1 April 2024 will reopen 48 hours after the declaration of the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31 March 2024. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we would like to inform you that the Board of the Company at its' meeting held today i.e. on 25 April 2024, inter-alia has considered and approved the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31 March 2024 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we would like to inform you that the Board of the Company at its' meeting held today i.e. on 25 April 2024, inter-alia has considered and approved the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31 March 2024 Audited Financial Result (Standalone & Consolidated) for the quarter and year ended 31.03.2024 The Board of Directors at its meeting held on 25.04.2024 inter-alia has re-appointed: 1. Mr. Anurag Choudhary as Chairman cum Managing Director & CEO for a further term of five years w.e.f 14.08.2024 2. Mr. Amit Choudhary as a Whole-time Director for a further term of five years w.e.f 14.08.2024 Read less.. The Board of Directors at its meeting held on 25.04.2024 inter-alia has approved the appointment of Secretarial Auditor and re-appointment of Internal Auditor (As per BSE Announcement Dated on 25/04/2024)
15-Mar-2024	20-Mar-2024	Preferential Issue	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2024 inter alia to consider and approve Notice pursuant to Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) is scheduled to be held on Wednesday the 20 March 2024 inter-alia to consider and approve the following: 1. Proposal for issuance of equity shares by way of preferential allotment in accordance with the applicable law subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company; 2. Proposal for raising of funds by way of issuance of equity shares / preference shares / bonds / debentures / warrants or any other eligible securities through permissible modes including but not limited to Preferential Issue Private Placement Qualified Institutions Placement or any equivalent capital raising mode or combination of methods. Board of Directors of Himadri Speciality Chemical Ltd ('Company') at its meeting held today, i.e., on 20.03.2024 inter-alia has considered and approved the following: 1. Acquisition of 40% equity shares of Invati Creations Private Limited. 2. Issue of Equity Shares of the Company on preferential basis, for consideration other than cash. 3. Preferential issue of warrants. 4. Seeking approval of shareholders for issuance of securities on a preferential basis through Postal Ballot. The Meeting of the Board of Directors commenced at 11.00 a.m. (IST) and concluded at 12:50 p.m. (IST) We request you to kindly take on record the same Pursuant to Regulation 30 of the SEBI(LODR) Regulations, 2015 we would like to inform you that the Board of Directors at its meeting held on 20.03.2024 has inter-alia approved the 1. Issue of equity shares of the Company on preferential basis, for consideration other than cash; 2. Preferential issue of Warrants; (As Per BSE Announcement dated on 20.03.2024)
09-Jan-2024	16-Jan-2024	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/01/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Tuesday 16 January 2024 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31 December 2023. We would like to inform you that the Board at its meeting held today i.e on 16.01.2024, inter-alia has considered and approved the unaudited financial results (Standalone and Consolidated) for the quarter and nine months ended 31.12.2023. We would like to inform you that the Board at its' meeting held today i.e., on 16 January 2024, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2023. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31 December 2023. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2023. (As Per BSE Announcement Dated on 16/01/2024)
06-Dec-2023	05-Dec-2023	Acquisitions	Pursuant to Regulation 30 of SEBI Listing Regulations, this is to inform you that Himadri Clean Energy Limited, the WOS has informed the Company that it has proposed to acquire 100% shareholdings of Himadri Future Material Technology Limited to make it WOS. On completion of above acquisition Himadri Future Material Technology Limited will become a step down WOS of the Company. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), this is to inform you that the Board of Directors of the Company at its' meeting held on 5 December 2023, inter-alia has considered and approved setting up of the Manufacturing facility for the production of Lithium-ion Battery (LiB) components with total annual production capacity of 200,000 MT either directly and/or through its subsidiaries .
10-Oct-2023	17-Oct-2023	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Tuesday the 17 October 2023 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2023. We would like to inform you that the Board at its' meeting held today i.e., on 17 October 2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six-month period ended 30 September 2023. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and six-month period ended 30 September 2023. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six-month period ended 30 September 2023. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, this is to inform you that the Board at its meeting held today on 17 October 2023, inter-alia has considered and approved acquisition of 100% equity shares of Himadri Clean Energy Limited. We would like to inform you that the Board of Directors at its meeting held today i.e on 17 October 2023 inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six months period ended 30 September 2023. (As per BSE Announcement Dated on 17/10/2023)
11-Jul-2023	18-Jul-2023	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Tuesday the 18 July 2023 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter ended 30 June 2023. We would like to inform you that the Board of Directors at its meeting held on 18.07.2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023. We are enclosing herewith Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023 along with Limited Review Report. We request you to kindly take on record the same. We would like to inform you that the Board at its' meeting held today i.e. on 18 July 2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2023. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023. The Meeting of the Board of Directors commenced at 6.00 p.m (IST) and concluded at 7:15 p.m.(IST) We request you to kindly take on record the same. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors at its meeting held on 18.07.2023, inter-alia has considered and approved acquisition of 100% Equity Shares of Combe Projects Private Limited. (As Per BSE Announcement dated on 18.07.2023)
21-Apr-2023	28-Apr-2023	Accounts	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Friday the 28 April 2023 inter-alia to consider the following: 1. To approve and take on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2023; 2. To recommend payment of Dividend if any Final Dividend & Audited Results (As per BSE Bulletin dated on 21/04/2023) We are enclosing herewith the following pursuant to Regulation 30 and 33 read with the applicable provisions of Schedule III and IV of the SEBI (LODR) Regulations, 2015: Audited Financial Results i) Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31 March 2023 along with Auditors Report thereon; ii) Statement of Assets and Liabilities (Standalone & Consolidated) for the financial year ended 31 March 2023; iii) Audited Cash Flow Statement (Standalone & Consolidated) for the financial year ended 31 March 2023; iv) Declaration of Managing Director & CEO on Audit Reports with unmodified opinion pursuant to Regulation 33(3) (d) of SEBI (LODR) Regulations, 2015. 2. Declaration of Dividend The Board has recommended to the shareholders a final dividend of Re. 0.25 per equity share of Re 1 each (i.e. 25% of face value of equity share) for the FY 2022-23; The Meeting of the Board of Directors commenced at 5:00 pm and concluded at 7:00 pm. We would like to inform you that the Board at its' meeting held today i.e. on 28 April 2023, inter-alia has considered and approved the following: 1. Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31 March 2023. 2. Declaration of Dividend The Board has recommended to the shareholders a final dividend of Re. 0.25 per equity share of Re 1 each (i.e. 25% of face value of equity share) for the FY 2022-23; Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this to inform you that the Board at its' meeting held on today i.e, on 28 April 2023, inter-alia has recommended to the shareholders a final dividend of Re 0.25 per equity share of Re 1 each (i.e. 25% of face value of equity share) for the Financial Year 2022-23. The above dividend, if declared by the shareholders at the ensuing Annual General Meeting will be credited/ dispatched within 30 days from the date of declaration. The record date for determining entitlement of the members to final dividend shall be intimated in due course. The Meeting of the Board of Directors commenced at 5:00 pm and concluded at 7:00 pm. We request you to kindly take on record the same. (As Per BSE Announcement Dated on 28.04.2023)
03-Feb-2023	10-Feb-2023	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Friday the 10 February 2023 inter-alia to approve and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31 December 2022. We would like to inform you that the Board at its' meeting held today i.e. on 10 February 2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2022. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31 December 2022. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2022. The Meeting of the Board of Directors commenced at 5.30 p.m and concluded at 6:20 p.m. (As Per BSE Announcement dated on 10.02.2023)
21-Oct-2022	29-Oct-2022	Quarterly Results	Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2022 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Saturday the 29 October 2022 inter-alia to approve and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2022. We would like to inform you that the Board at its' meeting held today i.e. on 29 October 2022, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30 September 2022. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30 September 2022. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six months ended 30 September 2022. The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 5:00 p.m. We would like to inform you that the Board at its' meeting held today i.e. on 29 October 2022, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30 September 2022. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30 September 2022. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six months ended 30 September 2022. The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 5:00 p.m. (As Per BSE Announcement Dated on 29.10.2022)

1 2

LOGIN HERE

Himadri Speciality Chemical Ltd

Board Meeting